Using mathematical modeling to bridge phase 3 microbicide trials with public health decision making

J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):434-5. doi: 10.1097/QAI.0b013e31819461ab.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS Vaccines / immunology
  • Anti-Infective Agents / therapeutic use*
  • Clinical Trials, Phase III as Topic*
  • Decision Making*
  • HIV Infections / prevention & control*
  • Humans
  • Models, Theoretical
  • Public Health*
  • Randomized Controlled Trials as Topic

Substances

  • AIDS Vaccines
  • Anti-Infective Agents